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Abstract 
 
Background:  Death rates on liver transplant waiting lists range from 5%-25%. 
Herein, we report a unique experience with 50 anonymous persons who volunteered 
to address this gap by offering to donate part of their liver to a recipient with whom 
they had no biological connection or prior relationship (A-LLD).   
Methods: Candidates were screened to confirm excellent physical, mental, social, and 
financial health. Demographics and surgical outcomes were analyzed. Qualitative 
interviews after donation examined motivation and experiences. Validated self-
reported questionnaires assessed personality traits and psychological impact.  
Results: 50 A-LLD liver transplants (LT) were performed between 2005 and 2017. 
Most donors had a university education, a middle-class income, and a history of prior 
altruism. Half were women. Median age was 38.5 years (range 20-59 yrs.). Thirty-
three (70%) learned about this opportunity through public or social media. Saving a 
life, helping others, generativity, and reciprocity for past generosity were motivators. 
Social, financial, healthcare, and legal supports in Canada were identified as 
facilitators. A-LLD identified most with the personality traits of agreeableness and 
conscientiousness. The median hospital stay was six days. There was one Dindo-
Clavien Grade 3 complication that completely resolved. One-year recipient survival 
was 91% in 22 adults and 97% in 28 children. No A-LLD reported regretting their 
decision.   
Conclusions: This is the first and only report of the motivations and facilitators of A-
LLD in a large cohort. With rigorous protocols, outcomes are excellent.  A-LLD has 
significant potential to reduce the gap between transplant organ demand and 
availability.  
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Lay Summary: 
 We report a unique experience with 50 living donors who volunteered to donate to a 
recipient with whom they had no biological connection or prior relationship 
(anonymous living donors). This report is the first to discuss motivations, strategies and 
facilitators that may mitigate physical, social and ethical risk factors in this patient 
population. With rigorous protocols, anonymous liver donation and recipient outcomes 
are excellent; with appropriate clinical expertise and system facilitators in place, our 
experience suggests that other centers may consider the procedure for its significant 
potential to reduce the gap between transplant organ demand and availability. 
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INTRODUCTION  
Death rates on liver transplant (LT) waiting lists (WL) in the Western world range from 
5-25%
1-4
. This is disheartening since most LT recipients now survive for decades with 
good health and near normal quality of life
1,5,6
. In selected locations, live liver donation 
(LLD) has been used to mitigate the shortage of deceased donor livers with excellent 
recipient outcomes. LLD is associated with a 30% morbidity rate and an estimated 0.3% 
donor mortality risk
5,7-11,12
. Our program and others have confirmed that donors with 
biological relationships or close emotional bonds with the recipient have few regrets
8,13
.  
 
Early in the development of our LLD program, a donor candidate challenged the 
requirement for a pre-existing connection between the live donor and recipient. We 
acknowledged that few centers offer anonymous kidney donation but noted that the 
latter operation is associated with a much smaller risk. Nonetheless, after a thorough 
ethical review, we decided to cautiously develop a unique program for anonymous-LLD 
(A-LLD) and reported favorable preliminary outcomes
13,14
. Herein, we report the 
characteristics and surgical outcome of the larger A-LLD experience (n=50 cases) to 
date. Moreover, we provide rigorous quantitative/qualitative study data from 26/50 A-
LLD who agreed to participate in a mixed methods study about their A-LLD 
experiences. We explored the reasons why people volunteer to become LLD despite the 
significant risks; factors that facilitate this choice; how they feel about this choice 
afterwards; and the potential of this option to reduce deaths on LT WL.  
 
A-LLD has the potential to alleviate suffering for those waiting for LT. In December 
2016, there were 11,140 active patients waiting for a LT in the United States. Also, in 
that period of time 192,947,800 individuals constituted the US population between the 
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ages of 18 and 65. Therefore, if approximately 1 of 17,000 US citizens between this 
ranges of age volunteered to donate part of their liver, the entire waitlist could be 
eliminated. We hope that the good outcomes with A-LLD reported herein will 
incentivize other programs to consider developing their own protocols for this option.    
 
METHODS 
Study Design  
A mixed methods approach was used to characterize the A-LLD experience.  This study 
was approved by University Health Network’s Research Ethics Board (REB #:16-5038-
AE). 
 
We define A-LLD as a donor with no biological connection and whose identity was 
unknown to the recipient when starting the assessment. A-LLD were either directed or 
non-directed. Directed donors donated to a specific individual without the recipient’s 
knowledge. Non-directed donors provide this gift to someone selected by the recipient 
team
13,15
. 
 
Participants 
From January 2005 to December 2017, we performed 2037 adult and pediatric liver 
transplants in Toronto. The study sample includes all patients undergoing A-LLD at the 
Toronto General Hospital between April 2005 and May 2017. A detailed description of 
our evaluation and selection process has been reported
5,16
. Briefly, all A-LLD are 
selected based on compliance with the Health Canada regulations for safe organ and 
tissue donation and transplantation
17,18
. In addition to a careful medical and surgical 
work-up, all anonymous donor candidates between ages 16-60 are seen by both social 
work and psychiatry to assess their mental health, motivation, social independence, 
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willingness to comply with our ethical policies, and support systems. Comprehensive 
assessments of donor physical and mental health are performed by our team at 1 and 3 
months after surgery (or longer if needed) and by the primary care provider annually for 
10 years post-donation.  
 
Anonymous, directed donors were allocated to their intended recipients if suitability for 
the specific recipient was met (e.g. blood type, graft volume and anatomy). If they were 
not suitable, they were offered the opportunity to donate to another recipient. Non-
directed A-LLD were given the option to donate to either a child or an adult. We 
recommended donating the left lateral segment (LLS) as the first option because of the 
lower risks compared with donation of a full left or right lobe graft (RL)
11,19-22
 but 
respected the donor’s autonomy to make an informed decision to donate to an adult if 
that was their preference. Differences in risks between the different donor procedures 
were explained in detailed to the potential donors in order for them to be able to take an 
informed decision. When a LLS hepatectomy was not possible due to either anatomical 
considerations or due to the absence of an available compatible recipient, RL donation 
was offered. The transplant hepatology team independently selected these recipients 
based on priority of medical need. Donors, besides knowing if their intended recipients 
were either a child or an adult, were not provided with any other additional information 
regarding the recipients.  
 
The first A-LLD operation was performed in April 2005. Shortly thereafter we reported 
this case and discussed the ethical basis for A-LLD-LT
14
.
 
When evaluating A-LLD 
candidates, we payed particular attention to: motivation, decision-making, resilience, 
prior altruism, community service, and social support. Donors were excluded if they 
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demonstrated significant instability in psychiatric/psychosocial functioning or require 
intensive support to maintain stability. Donors were reminded that Canadian law 
prohibits profiting in any material way from the donation. Provincial funding provides 
partial reimbursement of expenses directly incurred through donation.  
 
In 2010, we started asking A-LLD to maintain their anonymity to be congruent with 
Canadian legal requirements for anonymity with deceased donation
23
. Donors were 
informed of the immediate transplant outcome but were not informed about the 
recipient’s longer-term condition. We offered to facilitate an exchange of a brief card or 
letter without identifying information. We did not facilitate meetings between the donor 
and the recipient although a few pairs have done this through their own initiatives using 
social media.  
 
Medical, Surgical, and Socioeconomic Data 
Medical and surgical data were extracted from our prospectively collected database. 
Socioeconomic data were extracted from template social work assessments. Mean 
household income, residency (defined as urban versus rural), and cultural diversity 
index (defined as high, medium, or low) were approximated from postal code using 
Postal Code
OM
 Conversion File Plus, Version 6C (Statistics Canada, Ottawa, ON, 
Canada) and PRIZM5 (Environics Analytics, Toronto, ON, Canada) and compared with 
normative population data. Where relevant and when data were available, comparison 
was made with normative population data or the Ontario National Household Survey 
Profile 2011 (Statistics Canada Catalogue no. 99-004-XWE, Ottawa, ON, Canada).  
 
Donor Quantitative Self-Report Data 
Of the 50 identified A-LLD, those who were at minimum three months post-donation 
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(41/50) were invited to complete structured questionnaires, 26 agreed. From the 
remaining donors (15/41), 12 participants could not be reached and three (6%) declined 
participation due to lack of interest. Post-donation medical and psychosocial follow-up 
was distinct from this process; while only a portion of donors agreed to participate in 
the study, all donors completed all of the required medical follow-up post-donation and 
were subsequently discharged to their primary care provider with a full case summary 
for ongoing care.  
 
Personality dimensions were explored using the Big Five Inventory, which assesses the 
degrees of extraversion, agreeableness, conscientiousness, neuroticism and openness
24
. 
The 4-item Relationship Questionnaire was used to measure adult attachment styles
25
.  
It was selected to explore potential associations between the ways in which individuals 
form relational attachments and the impact this has on the donation decision given some 
evidence that secure attachment increases compassion and altruism
24
. The Post-
Traumatic Growth Inventory (PTGI)
26
 was administered to examine positive changes 
donors might have experienced. The PTGI was administered with a preamble 
explaining that donors have described LLD as a positive but unexpectedly difficult 
experience in order to clarify the original instructions in which the event in question is 
referred to as a “crisis/disaster.” 
 
Donor Qualitative Data 
Everyone who completed the structured questionnaires participated in semi-structured 
qualitative interviews. Transcripts were independently coded during data collection to 
identify emerging themes, often by identifying unique terms used by the participants 
themselves (e.g. “Life changing”)27. During the interview process, the investigators met 
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as a group to reach consensus on key codes and themes directly related to the project 
objectives and recurring across multiple interviews
28
. To confirm importance and 
identify associations, transcripts were critically re-analyzed using the constant 
comparison method
28
.  
 
Statistical Analysis 
Data are shown as median (range) or number (percentage) unless otherwise stated. Data 
were analyzed for significance using SPSS 22 statistical package (IBM, Chicago, USA). 
A p value of <0.05 was considered significant. 
 
 
RESULTS 
A-LLD Characteristics 
In the study period, 743 LLD were performed at our institution. Fifty (6.7%) were 
performed anonymously. The annual rates of anonymous donation have been stable for 
the past 5 years. Self-reported questionnaires were received from 26 (63%) patients out 
of the 41 A-LLD who were more than 3 months post-donation. All respondents also 
volunteered to participate in a qualitative interview.  
 
Donor characteristics are summarized in Table 1. Fifteen (30%) A-LLD were directed, 
having learned of the specific recipient’s need through media appeals and community 
news. Over half of donations (n=28, 56%) went to a pediatric recipient while the 
remainder (n=22, 44%) went to adult recipients.   
 
Twenty-six (52%) were women and 24 (48%) men. Median age was 38.5 years (range 
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20-59 yrs.). Most were Caucasian (n=47, 94%). Many were married or in a common-
law relationship (54%) and many had children (40%). Figure 1 depicts their 
socioeconomic status compared with Ontario normative populations. 
 
How Donors Learned About Living Liver Donation as an Option 
More than two thirds of donors (n=33, 70%) came forward after learning about the 
growing need for organ donation through media appeals on behalf of patients on the 
transplant waiting list in local, national or social media. Only eight donors knew 
somebody who has been a solid organ transplant recipient. Twenty seven patients found 
out through the media about the organ shortage, a patient in need of a LT or stories 
about previous live donors; six patients found out through their community involvement 
(e.g. place of work, church/temple, etc.) about somebody in need for a LT; six donors 
knew somebody in need of a LT but upon finding they would not be a suitable match, 
opted for non-directed donation; five donors directed to someone with whom they had 
an existing relationship but wished to remain anonymous; three had a family member 
who benefitted from LT and wanted to reciprocate; one was previously a bone marrow 
donor and felt that he wanted to do more; one had a relative die while waiting for a LT; 
one donor was a healthcare professional who had witnessed many patients affected by 
the need for transplant.  
 
 History of Altruism 
The majority of donors (n=34, 68%) had a history of altruistic acts prior to liver 
donation. This included volunteer work in their local community and/or with 
international charity organizations (n=23, 46%), regular or ad hoc blood donation 
(n=20, 40%), and solid organ donation (n=3, 6%). Two of the donors had a prior history 
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of anonymous living kidney donation. One donor underwent bone marrow donation 
prior to liver donation. Median evaluation time for all donors was of 94 (18-681) days.  
 
Response to Public/Media Appeals 
The flow of donor applications and their outcomes during the study interval is shown in 
Figure 2. During the study interval, in addition to the completed donations described, 
there were another 637 anonymous donor candidate applications received. From them, 
536 (84%) candidates submitted as directed donors in response to media appeals of 
various scales or advocacy on behalf of recipients by family members. The remaining 
101 (16%) submitted as non-directed donors. Of the directed donor group, 509 (95%) 
donor files were closed after the intended recipient received a transplant and before the 
formal donor work-up was initiated. Upon notification of their file closure, 27 (5%) 
candidates indicated they wished to be considered as non-directed donors in response to 
a missed opportunity to donate to the individual for whom they responded initially. Of 
the combined non-directed group of 128 donors, 74 (58%) were rejected after reviewing 
the screening questionnaire, most commonly due to a body mass index higher than the 
upper maximum of 35 kg/m
2
 or health-related contraindications. The remaining 54 
(42%) non-directed donors were rejected at various stages after starting a work-up due 
to medical or anatomical unsuitability.  
 
Donor Surgical Outcomes 
Donor surgical outcomes are summarized in Table 2. Thirteen donors (26%) 
experienced a complication (Table 3). Only one major complication (Dindo-
Clavien≥3b) occurred. This donor required re-operation to evacuate a hematoma. 
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Median hospital stay was 6 (4-11) days. Median time to return to work was 12 weeks 
(3-24 weeks). One donor with a deep vein thrombosis has persistent leg edema that 
limits vigorous physical activity. 
 
Personality Traits 
When compared with the general population. A-LLDs had higher scores on the Big Five 
Inventory
22 
in Agreeableness (mean = 4.24, SE = 0.11, p<0.0001) and 
Conscientiousness (mean = 4.28, SE = 0.09, p<0.0001); and lower scores on 
Neuroticism (mean = 2.27, SE = 0.15, p<0.0001).  
 
Attachment Style 
Close to half of the respondents (13 donors, 50%) identified with secure attachment 
(Table 4). A third of respondents (8 donors) identified with a dismissing attachment 
style. Four (15%) respondents reported having a fearful attachment style. 
 
Perspectives on Anonymity 
Forty-four donors (88%) maintained anonymity. The remaining six donors (12%) met 
their recipients or their families, personally or in an indirect manner through electronic 
media. One of the donors experienced mild distress related to the recipient family 
pursuing more contact than they were comfortable with, which resolved with 
counseling. Three donors who disclosed to their recipient were interviewed. During 
those interviews, donors noted that it was gratifying to see the result of their donation 
and reported that they do not regret the disclosure. 
 
Psychological Growth Subsequent to A-LLD 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
   16 
 
Figure 3 summarizes self-reported post-traumatic growth. Significant growth was 
reported in Relating to Others subscale (mean=10.33, SD=7.2); of these, “I more clearly 
see that I can count on people in times of trouble,” and “I learned a great deal about how 
wonderful people are,” were most strongly identified as areas of change with 
endorsement at a moderate score of ≥3 by 41% and 44% of respondents respectively.  
 
The Themes Arising from the Qualitative Interviews 
Major themes that emerged during the qualitative interviews are summarized in Table 5. 
Data saturation was achieved when using grounded theory for this analysis. Information 
from the final interviews did not yield new concepts and the relationships between the 
categories were clear. The concept of a good deed, a random act of kindness that would 
contribute to helping someone in need without the expectation of reciprocity or 
repayment, was identified as a core motivator. As healthy individuals, the moral 
obligation to help someone in need was frequently mentioned as a major factor and a 
moral imperative in decision-making to donate. Many reported an emotional reaction to 
an appeal from a potential recipient in the news or social media, in some cases making 
associations with their personal histories or relationships. Most believed that anonymity 
helped to preserve the value of doing a good deed.  
 
Finances and practical arrangements for work or family matters were reported as 
challenging factors in the donation process. Universal healthcare and generous 
employment benefits were facilitators. Most donors reported increased confidence in 
their ability to cope with problems and connect with others as a result of overcoming 
these challenges.  
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Validation in the health and strength of their own bodies were frequently reported in 
statements about impact post-donation. Donors were grateful that they were sufficiently 
fit to donate and reported feeling empowered by the process of recovering their health.  
No A-LLD expressed regret.  
 
Transplant Outcomes 
Supplementary Table 1 summarizes the recipients’ characteristics (e.g. age, gender). 
The main indication for LT in the pediatric population was biliary atresia (39%), 
followed by a metabolic disease (32%). In the adult population, the main indication for 
LT included primary sclerosing cholangitis (23%), Hepatitis C (18%), and alcoholic 
cirrhosis (18%). 
 
Graft and patient survival for the pediatric population at 1-, 3- and 5-years was of 97%. 
Graft and patient survival for the adult population at 1-, 3- and 5-years was 
91%/86%/81% and 91%/86%/86%, respectively.  
 
DISCUSSION 
We performed our first A-LLD in 2005
14
. Motivated by improvement in a friend’s 
quality of life after solid organ transplantation, a 45-year-old man stepped forward 
offering to donate the LLS of his liver to any suitable child. He challenged our initial 
practice of restricting donation to those with a direct biological or strong emotional 
connection with the recipient by asserting 1) he was entitled to make well-informed 
autonomous decisions about undertaking voluntary health risks; and 2) we should seize 
this opportunity because saving lives is the most important human and healthcare 
system value
13
.   
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Why do people volunteer to donate part of their liver to a stranger? The qualitative 
interviews reveal a perceived moral duty to step forward given good health and the 
great need. Public appeals are credited with raising awareness of the opportunity to save 
a life by these means. Some personalize the experience of the unknown recipient, 
stating that they hope that someone else would do this for them should they ever 
become ill with liver failure. Giving back in acknowledgement of a privileged life is 
another prevalent motivation. Some identify a desire for reciprocity recalling a specific 
event or time in their life when others helped them. Finally, many note that anonymous 
donation is a more accurate term than altruistic donation since the donor also benefits 
from a thorough work-up and the satisfaction of helping others in an extraordinary way.  
 
A-LLD were predominantly Caucasian, well-educated, financially secure, socially-
supported urban residents from many different walks of life. Their stable personal 
circumstances and gainful employment facilitated decisions to donate anonymously. 
Thirty-five (70%) had a history of prior altruistic acts before becoming a LLD. We 
elected to move forward with the 30% who did not have a history of prior altruistic acts 
based on their clinical presentation and our careful social work and psychiatry 
evaluations.  
 
Whether it is reasonable for a single individual to undergo two living donations raised 
safety and ethical questions for the program; several cases were approved following a 
detailed assessment in compliance with standards under the Canadian Standards 
Association Cells, Tissues and Organs for Transplantation: General Requirements
17,18
. 
Four donors either were or subsequently became live kidney donors. An additional three 
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donors have completed kidney donation assessments and are currently awaiting 
recipient matching, while one has anonymously donated bone marrow.  
 
Seventy percent of the A-LLD became aware of the opportunity to donate through 
social and public media appeals. This group fell into three broad categories: a) those 
who donated directly to the intended recipient, b) those who responded to an appeal for 
an individual but donated to someone else after a missed opportunity, and c) those who 
stepped forward without a specific recipient in mind after learning of LLD through 
media or their community. Information about the liver’s ability to regenerate itself to 
restore normal function and the lack of alternative treatment options for liver failure 
were frequently cited as an important reason to opt for liver donation instead of kidney 
donation.  Concerns about fairness, privacy and risk of donor and recipient exploitation 
have been raised with respect to public solicitation of living organ donation.  We have 
tried to address these issues by strictly adhering to transparent medical, legal, and 
ethical policies guiding directed live donation
31
. 
 
Those who knew the identity of their recipient reported a heightened level of distress 
during and after donation about protecting their identity. This group focused on the fact 
that disclosure of their identity may bring unwanted attention and create unrealistic 
expectations of their character. Moreover, donors in this group worried about their own 
expectations of the recipient, expressing that knowing too much about the recipient or 
establishing a relationship with them might be an unfulfilling experience or change their 
impression of the experience. This group reported that they felt protected by the 
anonymity policy with which they were prepared during the assessment process. 
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Bioethics, clinicians, regulatory groups and other content experts were consulted in 
formulating our policies around anonymity and disclosure.  Given reported concerns 
from donors and the potential detrimental impact to both donors and recipients in the 
case of a negative outcome, the program completely anonymizes the process of A-LLD 
and does not engage in donor-recipient disclosure.  
 
Structured questionnaires revealed personality traits that facilitated calculated risk-
taking to help others. Donors identified themselves as agreeable, conscientious, orderly 
and responsible with low neuroticism. These traits are consistent with literature showing 
that securely attached individuals find comfort in reciprocity and close relationships 
with others, exhibit greater compassion, have a greater willingness to help others in 
distress or need, and have fewer egoistic motives
24,29
. While a fearful-avoidant 
attachment style is inversely related to the helping behavior, engagement may be 
associated with a more egoistic motive (e.g. a sense of belonging, the satisfaction of a 
good deed). While such individuals also tend to experience challenges with seeking 
assistance and depending on others, individuals in this cohort nevertheless had a 
positive outcome with appropriate screening and support. The present analysis suggests 
that these collective personality traits are also associated with a low risk of experiencing 
regret or poor quality of life following LLD
30
.   
 
Donor and recipient physical outcomes in the anonymous cohort were similar to the 
outcomes reported for directed donation to individuals with whom the donor has a 
biological or close emotional relationship
5,9
. Overall and major complication rates were 
26% and 2% respectively. A-LLD acknowledged that this experience was not easy but 
believed that they also benefited by gaining insight into their personal strength and the 
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value of key relationships.  
 
This study has limitations and strengths. Biases or confounding factors may have been 
introduced by mixing retrospective and contemporaneous data collection. There is an 
opportunity to compare non-A-LLDs as a control group, an analysis which is currently 
underway. As with all surveys, we do not know the views of the non-respondents and 
this report may exclude understanding of poorer outcomes or experiences. However, the 
response rate of 51% is consistent with other qualitative research studies and data 
saturation was achieved when using grounded theory for the qualitative analysis. Our 
consistent protocol-driven processes for donor evaluation, donor acceptance, surgery, 
and post-operative follow-up are other strengths.  
 
We have previously reported our perspectives on the ethical foundation for A-LLD, 
proposing that decisions about candidates should be based on the ethical principles of 
autonomy, beneficence, non-maleficence, and informed consent
14
. Programs providing 
A-LLD face many challenging questions with no clear answers. For example, is it 
ethical to expose good Samaritans to surgical morbidity and even a risk of dying when 
there are options to use higher risks deceased donor organs treated with machine 
perfusion? Is it reasonable to let someone decide if they are willing to accept a slightly 
higher surgical mortality risk to donate a larger portion of their liver to an adult rather 
than a smaller portion of their liver to a child? Is it ethical to offer donation of a liver 
when someone has already donated a kidney and has slightly reduced renal function? 
Currently, Canadian regulations on living organ and tissue donor suitability assessment 
are limited to specific exclusionary criteria pertaining to behavioral risks of infection 
(Supplementary Table 2). These standards are important to minimizing potential health 
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risks to the recipient. Regulations currently provide guidance on a physical exam of the 
living donor in broad strokes, but the outcome remains dependent on the expertise, 
decision and confidence of the medical providers. However, the decision of suitability 
beyond infection risk must take in to consideration the nuances of donor history, 
psychosocial characteristics and a thorough review of the clinical assessment in its 
entirety. To ensure sound ethical decision-making and mitigation of safety risks as 
much as possible, our program has developed a donor-centric, expertise-based multi-
disciplinary approach. For example, when considering suitability of sequential liver and 
kidney donors, we consult specialists from both kidney and liver transplant teams, as 
well as independent medical consultants. A collaborative decision is made that complies 
with national regulations as well as expert opinion on overall clinical risk. Teams 
offering A-LLD are therefore, moral agents in this process and must carefully weigh the 
individual benefits and risks for each candidate. National regulatory bodies recognize 
that in order to optimize national programs and standards, a more coordinated model 
towards clinical governance is needed and programs are recommended to collaborate by 
standardize operating procedures that consider both recipient risks as well as donor 
safety. We continue to use our experiences to contribute to this effort.  
 
When discussing this experience, we were frequently asked: Can this experience be 
replicated elsewhere? It is up to others to answer this question, but we acknowledge 
many advantages that facilitate caring for these courageous volunteers. First, Canada’s 
publicly funded universal healthcare system eliminates the financial burdens that might 
otherwise be associated with donor assessment, surgery, and long-term care. Second, 
our legal system supports LLD through employee-friendly workplace regulations and 
reasonably generous social supports for those who become ill or disabled
30
. Third, the 
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Ontario government has reduced financial barriers by reimbursing most of the donor’s 
direct costs of LLD, including travel and accommodation expenses, a program for 
which all Ontario donors universally quality (PRELOD, Trillium Gift of Life). Fourth, 
Canadian culture supports live organ donation by valuing civic freedoms, compliance 
with laws, contributing to community, fairness, and a polite comfort with individual 
choice
31-32
. Reflecting these values and prevailing public views, Canadian media reports 
about altruistic donation have been generally positive. Lastly, our assessment process is 
focused on facilitating the generous intent of donor candidates without compromising 
safety.   
 
A-LLD not only saves the life of the transplanted recipient, it also reduces the demand 
on the deceased donor waiting list. A-LLD is particularly valuable for pediatric 
recipients because it provides healthy, high quality grafts and reduces the risk of 
recipients deteriorating on the wait list. Access to this option helped to reduce our 
pediatric wait list by 38% between the years 2014-2017 when A-LLD rates temporarily 
spiked due to multiple high-profile media solicitations. A-LLD comprises an overall 
small percentage of our LT activity. During the study period, 2.45% (50/2037) of our 
overall liver transplant activity and 6.73% (50/743) of our LLD activity was done 
through A-LLD. However, this option is a small but important part of a multifaceted 
effort at our center to reduce deaths on our liver transplant waiting list, complimenting 
other measures such as transplanting extended criteria deceased donor grafts with and 
without machine perfusion storage.   
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Table 1. Donor Characteristics 
Footnote: BMI, body mass index. 
 
 
  
 
 
 
 
Donor Characteristics 
 
N=50  
Median age at donation (years) 38.5 (20-59) 
Female  26 (52%) 
Median BMI at donation 24 (18-30) 
Previous surgery  25 (50%) 
Previous altruistic act  34 (68%) 
Other solid organ donation  4 (8%) 
Know a transplant recipient of a solid organ  8 (16%) 
Median evaluation time (days) 94 (18-681) 
Directed anonymous donation  15 (30%) 
Non-directed anonymous donation 35 (70%) 
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Table 2. Donor Surgical Outcomes 
 
Donor Surgical Outcomes N = 50 
Donation to a pediatric recipient  28 (56%) 
Right lobe donation  21 (42%) 
Left lobe donation  5 (10%) 
Left lateral segment donation  24 (48%) 
Intraoperative blood transfusion  1 (2%) 
Postoperative blood transfusion  1 (2%) 
Re-operation  1 (2%) 
Postoperative Complication  13 (26%) 
Postoperative complications within 30 days  10 (20%) 
Dindo-Clavien ≥3b  1 (2%) 
Long-term complication  3 (6%) 
Length of Hospital Stay (days) 6 (4-11) 
Hospital re-admission within 30 days  1 (2%) 
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Table 3. Donor Surgical Complications 
Footnote: DVT, deep vein thrombosis; PE, pulmonary embolism. 
 
N Complication Treatment Comments 
1 Clostridium Difficile colitis Antibiotics  
2 DVT and PE Anticoagulation Long-term leg edema 
3 Urinary tract infection Antibiotics  
4 Incisional hernia Surgical repair  
5 Intra-abdominal collection Percutaneous drainage  
6 Incisional hernia Surgical repair  
7 Subphrenic collection Self-resolved without drainage  
8 Pleural effusion Drainage  
9 Fever Self-resolved  
10 Brachial plexus injury Physiotherapy Ad-integrum recovery 
11 Intra-abdominal Hematoma Surgical evacuation  
12 Incisional hernia Surgical repair  
13 Postoperative ileus Fasting and IV fluids  
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Table 4. The Relationship Questionnaire 
 
Attachment 
Style 
Description 
Secure 
It is easy for me to become emotionally close to others. I am comfortable 
depending on them and having them depend on me. I don’t worry about 
being alone or having others not accept me. 
 
Dismissing 
I am comfortable without close emotional relationships. It is very 
important to me to feel independent and self-sufficient, and I prefer not to 
depend on others or have others depend on me.  
 
Preoccupied 
I want to be completely emotionally intimate with others, but I often find 
that others are reluctant to get as close as I would like. I am uncomfortable 
being without close relationships, but I sometimes worry that others don’t 
value me as much as I value them. 
 
Fearful 
I am uncomfortable getting close to others. I want emotionally close 
relationships, but I find it difficult to trust others completely, or to depend 
on them. I worry that I will be hurt if I allow myself to become too close to 
others.  
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Table 5. Major Qualitative Themes Associated with Anonymous Liver Donation 
Theme Quote 
Anonymity “I think [speaking about my donation] diminishes the real purpose of what I’ve 
done, because then it feels like I’m there because I’m looking for the accolades 
and that’s, I really don’t feel that’s why I did this.” 
 
Awareness 
 
 “I didn’t even know you could donate a liver. I had no idea any of this was 
possible. And I read that post [on Facebook] and I thought “Oh my God, ok, I’m 
the same blood type, so you need to help.” 
  
“I just think that people don’t think about it and the only time you do talk about 
organ donation or the only time it’s raised in the public consciousness is like the 
occasional news story.”   
Barriers and 
Facilitators 
to Donation 
 
“Frankly, if I didn’t have health insurance and if I was in a worse financial 
situation, I might not have been able to afford [to donate].”  
 
“So there’s the employer support, the insurance support and obviously, the 
biggest support is family. Your family has to be fully supportive of you.”  
 
Disclosure  “…when you start telling people you’re doing this, it’s automatically taken the 
wrong way by a lot of people.  People are generally really suspicious, so they 
think you’re doing it for money, which is unfortunate, because I had to raise 
money.  So, people would get the wrong impression that way.”   
 
“I’m uncomfortable, to some degree, talking about it with other people, because I 
don’t want people to get the impression that I did this for myself. Like, for some 
sort of boastful or, “Hey, look at me and look how great I…” Like that was never 
the intent.” 
Perceived 
gaps in care 
 
 
“I think from a doctor’s perspective, they checked in to say, “Your partner 
knows?” “Yeah.” “Okay, everything’s fine.” And everything was fine, but they 
never asked to see him. They never asked to talk to him…” 
 
“…like going from apprehension when you’re waiting to find out, to elation 
[when you are accepted as a donor], to like somebody gut-shot you or something 
[when you’re told you can’t donate]…I was devastated.” 
Impact of 
donation  
 
 
 
 
“I’m less fearful of what I can accomplish and less fearful of new experiences, 
and I enjoy busting through my comfort zone now.  I really enjoy it, because the 
best experiences in my life came from doing that.”  
 
“It was a good experience with my family. We’re all really close anyways, but it 
was something that we did together.  I don’t think I would have been able to do it 
myself …I needed people to help me during the first few days recovering so it 
was something that we did together.  And when you go through something like 
that it makes you closer.” 
 
“It’s the most important thing that I’ve done with my life so far.  It’s kind of nice 
to not just know that I did it, but to know that you can do things that seem a bit 
ridiculous or farfetched. It was really important.” 
 
“The entire experience has been kind of really falling in love with my body and 
how it works and appreciating all those amazing things that it can do.” 
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Reasons to 
Donate 
 
“I guess it’s a part of me that I’ll be leaving in this world. I couldn’t have 
children.  And so, people say, “Well, I want to have children so that when I go 
they know I’ve been here.”  Well, they’ll always know I’ve been here.” 
 
“Once I had personally become connected to the need, if there was any way 
possible that I could contribute, I was ready to do that.” 
 
 “And the reason I was looking [at anonymous donation] was because I have 
always enjoyed random acts of kindness…there was no way to pay it back and I 
liked putting that out into the world, because so many times, there’s ulterior 
motives.” 
 
“I have not led a perfect life. Nobody has. I haven’t been particularly awful. I 
haven’t been particularly fabulous. But, that if nothing else, this experience has 
given me the opportunity to point to one thing in my life that nobody could argue 
was wrong.” 
 
“There really wasn’t a decision to donate. I didn’t know that you could save 
somebody else’s life while you were still alive. I thought it was only post-mortem. 
So there was no decision. It was like, oh, you can do that. Then I’m in.”  
 
Perceptions 
of living liver 
donation  
“I just imagine the body as like a vehicle, right? Some people are dealt a lemon 
and if I have a spare part that can be helpful for someone else’s lemon, then I’m 
going to share it. That’s how I was thinking of it, this is my vehicle and we have 
this technology for a reason, so why not?”  
 
Relationships 
 
 
“I am embraced by the organ transplant community and they’re incredible. I’ve 
met so many people that are phenomenal people and it just keeps going.” 
 
“My dad and I definitely have this, we were really well bonded, but this incredible 
journey together from him, like literally being by my bedside when I was in the 
hospital every time, all my testing, everything, he was right there with me.” 
 
The 
Recipient 
 
 
 
 
 
 
 
 
 
 
“People said “Oh, it was a child, oh, you must feel so great.”  And I said, “Well, 
of course, but I would feel the same if it was an adult, because they deserve it just 
as much as anyone else. I didn’t want to be the person to make that decision.  I 
wanted it to be a decision based on what was the right fit. I didn’t want to be the 
one to narrow it down and create limitations.” 
 
“I don’t know anything about them. So I don’t have that emotional attachment.” 
 
“I wonder how they are. I wonder if they’re getting that second lease on life and if 
they’re taking advantage of it and if they’re pushing their own boundaries or, you 
know, what they're experiencing.” 
The Scar 
 
“It’s almost like all the trophies on my wall.  It’s like a trophy for me.  It was… 
it’s the marker of my experience and something I have been able to be a part of 
and achieve in my own life, so it’s essentially like a trophy.” 
 
“Even when I have a rough day, I can look back at my scar and think, you know 
what it really doesn’t matter, because you have saved somebody's life.” 
 
“Every time I look at this scar, it’s a reminder of how lucky I am to be fit and 
healthy.” 
 
Figure 1. Donor Socio-Demographic Characteristics 
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Figure 2. Flow of Donor Applications 2005-2017 
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Figure 3. Mean scores of Post-Traumatic Growth Inventory subscales and percent 
of donors endorsing significant growth (≥3) 
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687  
Total living liver donor applications received 
637 
Total Declined 
536 (84%)  
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Anonymous Living Liver Donation at the University of Toronto 
128  
Total Non-Directed 
74 (58%)  
Declined based on 
questionnaire 
54 (42%)  
Declined due to medical 
or anatomical 
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• Anonymous liver donors can successfully contribute to the donor organ pool.  
• Social media can be used to educate communities about this opportunity.  
• Anonymous donors are motivated by their values and beliefs and are very 
satisfied with their experience. 
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